Navolotskaya Elena V, Kovalitskaya Yulia A, Zolotarev Yury A, Sadovnikov Vladimir B
Branch of Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Science Avenue, 6, Pushchino, Moscow Region 142290, Russia.
J Pept Sci. 2008 Oct;14(10):1121-8. doi: 10.1002/psc.1049.
Selective agonist of nonopioid beta-endorphin receptor decapeptide immunorphin (SLTCLVKGFY) was labeled with tritium (the specific activity of 24 Ci/mmol). [3H]Immunorphin was found to bind to nonopioid beta-endorphin receptor of mouse peritoneal macrophages (Kd = 2.0 +/- 0.1 nM). The [3H]immunorphin specific binding with macrophages was inhibited by unlabeled beta-endorphin (Ki = 2.9 +/- 0.2 nM) and was not inhibited by unlabeled naloxone, alpha-endorphin, gamma-endorphin and [Met5]enkephalin (Ki > 10 microM). Thirty fragments of beta-endorphin have been synthesized and their ability to inhibit the [3H]immunorphin specific binding to macrophages was studied. Unlabeled fragment 12-19 (TPLVTLFK, the author's name of the peptide octarphin) was found to be the shortest peptide possessing practically the same inhibitory activity as beta-endorphin (Ki = 3.1 +/- 0.3 nM). The peptide octarphin was labeled with tritium (the specific activity of 28 Ci/mmol). [3H]Octarphin was found to bind to macrophages with high affinity (Kd = 2.3 +/- 0.2 nM). The specific binding of [3H]octarphin was inhibited by unlabeled immunorphin and beta-endorphin (Ki = 2.4 +/- 0.2 and 2.7 +/- 0.2 nM, respectively).
非阿片类β-内啡肽受体十肽免疫吗啡(SLTCLVKGFY)的选择性激动剂用氚进行了标记(比活度为24 Ci/mmol)。发现[3H]免疫吗啡能与小鼠腹腔巨噬细胞的非阿片类β-内啡肽受体结合(解离常数Kd = 2.0±0.1 nM)。未标记的β-内啡肽可抑制[3H]免疫吗啡与巨噬细胞的特异性结合(抑制常数Ki = 2.9±0.2 nM),而未标记的纳洛酮、α-内啡肽、γ-内啡肽和[Met5]脑啡肽则无此抑制作用(抑制常数Ki>10 μM)。已合成了30个β-内啡肽片段,并研究了它们抑制[3H]免疫吗啡与巨噬细胞特异性结合的能力。发现未标记的片段12 - 19(TPLVTLFK,即八肽吗啡的作者命名)是具有与β-内啡肽几乎相同抑制活性的最短肽段(抑制常数Ki = 3.1±0.3 nM)。八肽吗啡用氚进行了标记(比活度为28 Ci/mmol)。发现[3H]八肽吗啡能以高亲和力与巨噬细胞结合(解离常数Kd = 2.3±0.2 nM)。未标记的免疫吗啡和β-内啡肽可抑制[3H]八肽吗啡的特异性结合(抑制常数Ki分别为2.4±0.2和2.7±0.2 nM)。